ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VKTXW Viking Therapeutics Inc

4.60
0.00 (0.00%)
Jun 06 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -17.63M-16.2M-20.28M-20.54M-23.74M-27.27M-29.29M-34.07M
Pre Tax Income -17.43M-15.77M-19.56M-19.53M-19.23M-22.53M-24.61M-27.36M
Net Income -17.43M-15.77M-19.56M-19.53M-19.23M-22.53M-24.61M-27.36M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -17.63M-16.2M-20.28M-20.54M-23.74M-27.27M-29.29M-34.07M
EBITDA -17.63M-16.2M-20.28M-20.54M-23.74M-27.27M-29.29M-34.07M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -13.85M-19.07M-26.16M-32.69M-42.66M-55.68M-70.36M-100.83M
Pre Tax Income -14.73M-20.58M-22.06M-25.78M-39.5M-54.99M-68.87M-85.9M
Net Income -14.73M-20.58M-22.06M-25.78M-39.5M-54.99M-68.87M-85.9M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.707-0.575-0.308-0.356-0.539-0.703-0.905-0.859
EBIT -14.71M-20.58M-25.29M-32.83M-42.77M-55.7M-70.36M-100.83M
EBITDA -13.85M-19.07M-26.16M-32.69M-42.66M-55.68M-70.36M-100.83M

Your Recent History

Delayed Upgrade Clock